| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d8cee6cf94125415a7e7c3ee493d35d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_25318c7eb23be1bf0eeb56869c8a91ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b49b135f099e96a0e4cab2427a48ae8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f790e0fa57e652aa994a7cd44c94dbd3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a1ed0faa8a366a7d23cba50510e9e4ac |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-54 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-564
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57449 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-564
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-32 |
| filingDate |
2017-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32197f872cbad31ace72f372fc70362a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_962120ce9fb1a01334c58989f4c17463
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e40d7bc7162149c7c08113a24d888cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a845d367b9e9088460d6a2407522faa4 |
| publicationDate |
2018-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2018106810-A1 |
| titleOfInvention |
Detectors of serum biomarkers for predicting ovarian cancer recurrence |
| abstract |
Polypeptide marker antigens for detecting the presence of autoantibody biomarkers associated with ovarian cancer recurrence, each of the polypeptide marker antigens binding specifically to at least one autoantibody marker. An antibody binding assay for detecting the presence of autoantibody biomarkers associated with ovarian cancer recurrence, and methods for performing the assay. Methods for determining ovarian cancer recurrence in an ovarian cancer patient. A method for isolating antibodies specific for ovarian cancer by their affinity to the polypeptide marker antigens, and antibodies isolated by that method. |
| priorityDate |
2012-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |